## Abstract ## Aim This analysis evaluated the tolerability profile of quetiapine using data from all comparative controlled studies in patients with schizophrenia or related disorders in the AstraZeneca clinical trials database, focusing on extrapyramidal symptoms (EPS). ## Methods Adverse even
Microarray analysis of postmortem temporal cortex from patients with schizophrenia
✍ Scribed by Christopher Aston; Lixin Jiang; Boris P. Sokolov
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 98 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To examine molecular mechanisms associated with schizophrenia this study measured expression of approximately 12,000 genes in the middle temporal gyrus from 12 subjects with schizophrenia and 14 matched normal controls. Among the most consistent changes in genes with robust expression were significant decreases in the expression of myelination‐related genes MAG, PLLP (TM4SF11), PLP1, ERBB3 in subjects with schizophrenia. There was also altered expression of genes regulating neurodevelopment (TRAF4, Neurod1, histone deacetylase 3), a circadian pacemaker (PER1), and several other genes involved in regulation of chromatin function and signaling mechanisms. These findings support the hypothesis that schizophrenia is associated with abnormalities in oligodendroglia and provide initial evidence suggesting a role for epigenetic mechanisms and altered circadian rhythms in this disorder. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Objective To explore the relative association of adverse events with health‐related quality of life (HRQL) in patients (__N__ = 16 091) with schizophrenia, treated with antipsychotic medication. ## Methods In this __post hoc__ analysis of data from two 3‐year observational studies